PETER MILNER, MD

Cardiologist. CEO of Heart Metabolics. CEO, AshHill Pharmaceutical Investments. Founder, Optivia Biotechnology. SAB, Novartis Biomedical Research.

MICHAEL MARTIN, MD

Assoc Professor, UCSF Dept of Epidemiology and Biostatistics. Variety of medial executive positions.

PAUL AUERBACH, MD

Prof of Surgery and Chief of Div of Emergency Medicine, Stanford University. CMO of Healthline Networks. Former VC, Delphi Ventures, COO of  Sterling Healthcare Group.

TED McCLUSKEY, MD/PhD

Interventional Cardiologist, PhD Pharmacology. 20 years in Biotechnology industry. Former President Sand Hill Angels

JEFFREY KAPLAN, MD

Medical Director at Good Samaritan Hospital wound care center and a board certified vascular surgeon. Advisor and investor for Medtech companies.

TED TUSSING

Venture Associate, TriVentures. Former Dir for Corporate New Ventures at Stanford Univ Medical Center. Director at BioCardia.

M. CHRISTINE LEE, MD

Board-certified dermatologist and Asst Clinical Professor at UCSF. Specialist in Mohs micrographic surgery, skin cancer surgery and reconstruction.